Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07433153 · ClinicalTrials.gov registry record · NA

Comparison of Smartphone and Community-Based Delivery of the Otago Exercise Program for Fall Risk in Older Adults

A NA study of Fall and Frail Elderly, sponsored by Binghamton University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07433153: Recruiting NA study of Fall and Frail Elderly, sponsored by Binghamton University.

NCT07433153 is a NA study of Fall and Frail Elderly that is actively recruiting participants, run by Binghamton University. The registered enrollment target is 30 participants, below the 1,306-participant average among 19 other Fall trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07433153, a NA study of Fall and Frail Elderly, is actively recruiting participants, sponsored by Binghamton University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The long-term goal of this project is to effectively bridge the research-clinic-community gap and to foster partnerships that support the implementation, utilization, and advocacy of evidence-based fall prevention programs in the older adult community. The Otago Exercise Program (OEP) is an evidence-based fall prevention program that has been shown to reduce falls and fall-related injuries among older adults. Traditionally, OEP is delivered in the home by a physical therapist and focuses on muscle strengthening and balance training. Despite its proven effectiveness, adherence and compliance rates have been low. The personnel and resource demands of program delivery, along with challenges in monitoring participant adherence, represent significant barriers to broader implementation. Alternative delivery systems using remote and community-based platforms may help address these limitations. Specific Aim 1: To compare the effectiveness of two delivery modes of the Otago Exercise Program: a remotely delivered, home-based smartphone program and an in-person, community-based program. Specific Aim 2: To examine the feasibility, acceptability, and usability of the Otago Exercise Program delivered through both smartphone-based and in-person formats.

Primary Outcome

Self-selected walking speed (m/s) over level surface

Conditions Studied

Interventions

  • BEHAVIORAL Smartphone-Based Intervention
  • BEHAVIORAL Group-Based Intervention

Study Locations (1)

New York

  • Binghamton University - Binghamton

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-02-16
Est. Completion 2026-12-01
Phase NA
Binghamton University

7 total trials

What NCT07433153 shows while recruiting

NCT07433153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,306-participant average among 19 other Fall trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Fall appearing as the primary indexed condition, and to 2 interventions - of which Smartphone-Based Intervention is the first listed.

NCT07433153 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07433153 about?

NCT07433153 is a clinical study titled "Comparison of Smartphone and Community-Based Delivery of the Otago Exercise Program for Fall Risk in Older Adults". The long-term goal of this project is to effectively bridge the research-clinic-community gap and to foster partnerships that support the implementation, utilization, and advocacy of evidence-based fall prevention programs in the older adult community. The Otago Exercise Program (OEP) is an evidence...

What is the current status of trial NCT07433153?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-02-16. Estimated completion is 2026-12-01.

What conditions does trial NCT07433153 study?

This clinical trial studies the following conditions: Fall, Frail Elderly.

What interventions are being tested in trial NCT07433153?

The interventions under investigation include: Smartphone-Based Intervention (BEHAVIORAL), Group-Based Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07433153?

This trial is sponsored by Binghamton University, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07433153 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fall

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07433153's enrollment target sits among peer trials

30 14th of 19 higher than 5 of 19 other Fall trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fall trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07433153, the US trial registry maintained by the National Library of Medicine. NCT07433153 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.